Some studies have suggested that JNK is regulated in the enlarged prostate and/or during the proliferation of prostate stromal cells [50], while others found that an interaction with AR triggers JNK phosphorylation and downstream signaling to facilitate cell cycle progression in BPH and prostate cancer [51]. Here, AR is linked to benign prostatic hyperplasia.